• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗磷脂综合征的妊娠结局预测因素:系统评价和荟萃分析。

Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis.

机构信息

University Medical Center Utrecht, Wilhelmina Children's Hospital, Department of Obstetrics, Lundlaan 6, 3584 EA Utrecht, the Netherlands.

University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.

出版信息

Autoimmun Rev. 2021 Oct;20(10):102901. doi: 10.1016/j.autrev.2021.102901. Epub 2021 Jul 16.

DOI:10.1016/j.autrev.2021.102901
PMID:34280554
Abstract

OBJECTIVE

To identify and assess the magnitude of effect of pregnancy outcome predictors in women with antiphospholipid syndrome (APS) by means of systematic review and meta-analysis.

METHODS

PubMed and Embase were searched (13th June 2020) for studies reporting on pre-pregnancy risk factors of pregnancy outcomes in APS patients. Literature screening and data extraction were conducted by two reviewers independently, in a blinded standardized manner. Pooled univariate odds ratios (OR) were computed using a random effects model. Heterogeneity was assessed by I%.

RESULTS

The search yielded 3013 unique results; 27 records were included in this meta-analysis. Previous thrombosis was associated with a decreased live birth risk (OR 0.60, p < 0.01, I = 40%), increased neonatal mortality (OR 15.19, p < 0.01, I = 0%), an increased risk of antenatal or postpartum thrombosis (OR 6.26, p < 0.01, I = 0%) and an increased risk of delivering a small for gestational age neonate (SGA) (OR 2.60, p = 0.01, I = 0%). Patients with an APS laboratory category I (double or triple positivity) profile had a decreased live birth risk (OR 0.66, p < 0.01, I = 0%), an increased risk of SGA (OR 1.86, p = 0.01, I = 43%) and preterm birth (OR 1.35, p < 0.01, I = 49%). Triple positivity was associated with a decreased live birth risk (OR 0.33, p < 0.01, I = 68%), an increased risk of preeclampsia (OR 2.43, p = 0.02, I = 35%) and SGA (OR 2.47, p = 0.04, I = 61%). Patients with lupus anticoagulant positivity had an increased risk of preeclampsia (OR 2.10, p = 0.02, I = 48%), SGA (OR 1.78, p < 0.01, I = 0%) and preterm birth (OR 3.56, p = 0.01, I = 48%). Risk of bias assessment suggested considerable bias on study participation and statistical methods.

CONCLUSIONS

The results of this meta-analysis identified previous thrombosis, laboratory category I, triple positivity and lupus anticoagulant positivity as the most important predictors of adverse pregnancy outcomes. This up-to-date knowledge, can be used in preconception counseling and tailoring of obstetric care.

摘要

目的

通过系统评价和荟萃分析,确定并评估抗磷脂综合征(APS)女性妊娠结局预测因素的作用大小。

方法

检索 PubMed 和 Embase,查找报告 APS 患者妊娠前风险因素与妊娠结局的研究。两名审查员以盲法标准化的方式独立进行文献筛选和数据提取。使用随机效应模型计算汇总单变量比值比(OR)。使用 I²评估异质性。

结果

搜索结果产生了 3013 个独特的结果;27 项记录纳入了本荟萃分析。既往血栓形成与活产风险降低相关(OR 0.60,p<0.01,I=40%)、新生儿死亡率增加(OR 15.19,p<0.01,I=0%)、产前或产后血栓形成风险增加(OR 6.26,p<0.01,I=0%)和胎儿生长受限(SGA)新生儿风险增加(OR 2.60,p=0.01,I=0%)。APS 实验室分类 I(双重或三重阳性)患者的活产风险降低(OR 0.66,p<0.01,I=0%)、SGA(OR 1.86,p=0.01,I=43%)和早产(OR 1.35,p<0.01,I=49%)风险增加。三重阳性与活产风险降低(OR 0.33,p<0.01,I=68%)、子痫前期(OR 2.43,p=0.02,I=35%)和 SGA(OR 2.47,p=0.04,I=61%)风险增加相关。狼疮抗凝物阳性患者子痫前期(OR 2.10,p=0.02,I=48%)、SGA(OR 1.78,p<0.01,I=0%)和早产(OR 3.56,p=0.01,I=48%)风险增加。偏倚风险评估表明研究参与和统计方法存在相当大的偏倚。

结论

本荟萃分析的结果确定了既往血栓形成、实验室分类 I、三重阳性和狼疮抗凝物阳性是不良妊娠结局的最重要预测因素。这种最新知识可用于孕前咨询和产科护理的定制。

相似文献

1
Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis.抗磷脂综合征的妊娠结局预测因素:系统评价和荟萃分析。
Autoimmun Rev. 2021 Oct;20(10):102901. doi: 10.1016/j.autrev.2021.102901. Epub 2021 Jul 16.
2
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.
3
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.抗血小板和抗凝药物用于抗磷脂抗体个体血栓形成的一级预防。
Cochrane Database Syst Rev. 2018 Jul 13;7(7):CD012534. doi: 10.1002/14651858.CD012534.pub2.
4
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.不明病因复发性流产女性预防流产的孕激素治疗
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD003511. doi: 10.1002/14651858.CD003511.pub6.
5
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
6
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.不同的皮质类固醇药物和方案用于加速有早产风险的婴儿的胎儿肺成熟。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.
7
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2017 Oct 31;10(10):CD012024. doi: 10.1002/14651858.CD012024.pub2.
8
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3.
9
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
10
Antioxidants for male subfertility.抗氧化剂治疗男性不育。
Cochrane Database Syst Rev. 2022 May 4;5(5):CD007411. doi: 10.1002/14651858.CD007411.pub5.

引用本文的文献

1
Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis.抗磷脂综合征患者使用羟氯喹与妊娠结局:一项系统评价和荟萃分析
RMD Open. 2025 Aug 27;11(3):e005825. doi: 10.1136/rmdopen-2025-005825.
2
Placental Pathology in Obstetric Antiphospholipid Syndrome Beyond Thrombosis: A Case Report and Literature Review.产科抗磷脂综合征中除血栓形成外的胎盘病理学:一例报告及文献综述
J Clin Med. 2025 Jul 22;14(15):5172. doi: 10.3390/jcm14155172.
3
Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome.
凝血酶生成试验作为改善抗磷脂综合征疾病严重程度分层的有用工具。
RMD Open. 2025 Jul 1;11(3):e005489. doi: 10.1136/rmdopen-2025-005489.
4
Antiphospholipid syndrome in pregnancy: a comprehensive literature review.妊娠期抗磷脂综合征:一项全面的文献综述。
BMC Pregnancy Childbirth. 2025 Mar 24;25(1):337. doi: 10.1186/s12884-025-07471-w.
5
Spontaneous rupture of broad ligament vein in twin pregnancy: a case report and literature review.双胎妊娠阔韧带静脉自发破裂 1 例报告并文献复习
J Int Med Res. 2024 Nov;52(11):3000605241290898. doi: 10.1177/03000605241290898.
6
Maternal adiposity measures and hypertensive disorders of pregnancy: a meta-analysis.母体肥胖指标与妊娠高血压疾病:一项荟萃分析。
BMC Pregnancy Childbirth. 2024 Oct 16;24(1):675. doi: 10.1186/s12884-024-06788-2.
7
Recurrent Pregnancy Loss: Immunological aetiologies and associations with mental health.复发性流产:免疫学病因及其与心理健康的关联。
Brain Behav Immun Health. 2024 Sep 19;41:100868. doi: 10.1016/j.bbih.2024.100868. eCollection 2024 Nov.
8
The Hidden Relationship between Intestinal Microbiota and Immunological Modifications in Preeclampsia Pathogenesis.肠道微生物群与子痫前期发病机制中免疫调节的隐藏关系。
Int J Mol Sci. 2024 Sep 20;25(18):10099. doi: 10.3390/ijms251810099.
9
Perinatal outcomes in indian women with Antiphospholipid Antibody Syndrome (APS): Five year experience from a tertiary care centre.印度抗磷脂抗体综合征(APS)女性的围产期结局:来自三级医疗中心的五年经验
Eur J Obstet Gynecol Reprod Biol X. 2024 Aug 30;24:100340. doi: 10.1016/j.eurox.2024.100340. eCollection 2024 Dec.
10
B Cell Responses to the Placenta and Fetus.B细胞对胎盘和胎儿的反应。
Annu Rev Pathol. 2025 Jan;20(1):33-58. doi: 10.1146/annurev-pathmechdis-111523-023459. Epub 2025 Jan 2.